IMAC Holdings, Inc. Common Stock

Allarity Therapeutics announced the appointment of Jeff Ervin as its new Chief Financial Officer, succeeding Alexander Epshinsky. Ervin brings nearly two decades of executive leadership experience in healthcare and biotech sectors, and will support the company's clinical development of stenoparib, a cancer treatment drug.

Related tickers: ALLR, BACK, CING, CINGW.

IMAC Holdings, Inc. received a notification from Nasdaq regarding its failure to timely file its quarterly report. The company is working to file the report and regain compliance with Nasdaq's listing rules, but there is no assurance it will be able to do so within the required timeframe.

Related tickers: BACK.